Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04134390
Title Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR Study (CABOMAYOR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Spanish Oncology Genito-Urinary Group
Indications

renal cell carcinoma

Therapies

Cabozantinib

Age Groups: senior
Covered Countries ESP


No variant requirements are available.